Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2012 1
2015 1
2017 1
2022 1
2023 1
2024 5
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry.
Vitale A, Caggiano V, Martin-Nares E, Frassi M, Dagna L, Hissaria P, Sfriso P, Hernández-Rodríguez J, Ruiz-Irastorza G, Monti S, Tufan A, Piga M, Giardini HAM, Lopalco G, Viapiana O, De Paulis A, Triggianese P, Vitetta R, de-la-Torre A, Fonollosa A, Caroni F, Sota J, Conticini E, Sbalchiero J, Renieri A, Casamassima G, Wiesik-Szewczyk E, Yildirim D, Hinojosa-Azaola A, Crisafulli F, Franceschini F, Campochiaro C, Tomelleri A, Callisto A, Beecher M, Bindoli S, Baggio C, Gómez-Caverzaschi V, Pelegrín L, Soto-Peleteiro A, Milanesi A, Vasi I, Cauli A, Antonelli IPB, Iannone F, Bixio R, Casa FD, Mormile I, Gurnari C, Fiorenza A, Mejia-Salgado G, Kawakami-Campos PA, Ragab G, Ciccia F, Ruscitti P, Bocchia M, Balistreri A, Tosi GM, Frediani B, Cantarini L, Fabiani C. Vitale A, et al. Among authors: vitetta r. Semin Arthritis Rheum. 2024 Jun;66:152430. doi: 10.1016/j.semarthrit.2024.152430. Epub 2024 Mar 18. Semin Arthritis Rheum. 2024. PMID: 38554594 Free article.
Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registry.
Vitale A, Caggiano V, Leone F, Hinojosa-Azaola A, Martín-Nares E, Guaracha-Basañez GA, Torres-Ruiz J, Kawakami-Campos PA, Hissaria P, Callisto A, Beecher M, Dagna L, Campochiaro C, Tomelleri A, Frassi M, Franceschini F, Crisafulli F, Hernández-Rodríguez J, Gómez-Caverzaschi V, Araújo O, Sfriso P, Bindoli S, Baggio C, Sota J, Tufan A, Kucuk H, Piga M, Cauli A, D'Agostino MA, De Paulis A, Mormile I, Giardini HAM, Cordeiro RA, Lopalco G, Iannone F, Monti S, Montecucco C, Ruiz-Irastorza G, Soto-Peleteiro A, Triggianese P, Gurnari C, Viapiana O, Bixio R, Vitetta R, Rovera G, Conticini E, La Torre F, Portincasa P, Jaber N, Ragab G, Maher A, Batu ED, Ozen S, Wiesik-Szewczyk E, de-la-Torre A, Balistreri A, Frediani B, Fabiani C, Cantarini L. Vitale A, et al. Among authors: vitetta r. Front Pharmacol. 2025 Feb 19;16:1462254. doi: 10.3389/fphar.2025.1462254. eCollection 2025. Front Pharmacol. 2025. PMID: 40046741 Free PMC article.
Influence of Safety Warnings on the Prescribing Attitude of JAK Inhibitors for Rheumatoid Arthritis in Italy.
Paroli M, Becciolini A, Lo Gullo A, Parisi S, Bravi E, Andracco R, Nucera V, Ometto F, Lumetti F, Farina A, Del Medico P, Colina M, Ravagnani V, Scolieri P, Larosa M, Priora M, Visalli E, Addimanda O, Vitetta R, Volpe A, Bezzi A, Girelli F, Molica Colella AB, Caccavale R, Di Donato E, Adorni G, Santilli D, Lucchini G, Arrigoni E, Platè I, Mansueto N, Ianniello A, Fusaro E, Ditto MC, Bruzzese V, Camellino D, Bianchi G, Serale F, Foti R, Amato G, De Lucia F, Dal Bosco Y, Foti R, Reta M, Fiorenza A, Rovera G, Marchetta A, Focherini MC, Mascella F, Bernardi S, Sandri G, Giuggioli D, Salvarani C, De Andres MI, Franchina V, Molica Colella F, Ferrero G, Raffeiner B, Ariani A. Paroli M, et al. Among authors: vitetta r. J Clin Med. 2024 Jul 4;13(13):3929. doi: 10.3390/jcm13133929. J Clin Med. 2024. PMID: 38999494 Free PMC article.
Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA network.
Vitale A, Leone F, Caggiano V, Hinojosa-Azaola A, Martín-Nares E, Guaracha-Basañez GA, Torres-Ruiz J, Ayumi Kawakami-Campos P, Hissaria P, Callisto A, Beecher M, Dagna L, Tomelleri A, Campochiaro C, Frassi M, Crisafulli F, Franceschini F, Hernández-Rodríguez J, Gómez-Caverzaschi V, Araújo O, Sfriso P, Bindoli S, Baggio C, Sbalchiero J, Sota J, Tufan A, Vasi I, Piga M, Cauli A, D'Agostino MA, De Paulis A, Mormile I, Mayrink Giardini HA, Cordeiro RA, Gavioli F, Lopalco G, Iannone F, Montecucco C, Monti S, Ruiz-Irastorza G, Soto-Peleteiro A, Triggianese P, Gurnari C, Viapiana O, Bixio R, Vitetta R, Conticini E, La Torre F, Ragab G, Batu ED, González-García A, Peña-Rodríguez M, Bocchia M, Wiesik-Szewczyk E, Jahnz-Rózyk K, de-la-Torre A, Balistreri A, Frediani B, Fabiani C, Cantarini L. Vitale A, et al. Among authors: vitetta r. Front Pharmacol. 2025 Mar 7;16:1539756. doi: 10.3389/fphar.2025.1539756. eCollection 2025. Front Pharmacol. 2025. PMID: 40124776 Free PMC article.
Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritis.
Lo Gullo A, Parisi S, Becciolini A, Paroli M, Bravi E, Andracco R, Nucera V, Ometto F, Lumetti F, Farina A, Del Medico P, Colina M, Ravagnani V, Scolieri P, Larosa M, Priora M, Visalli E, Addimanda O, Vitetta R, Volpe A, Bezzi A, Girelli F, Molica Colella AB, Caccavale R, DI Donato E, Adorni G, Santilli D, Lucchini G, Arrigoni E, Platè I, Mansueto N, Ianniello A, Fusaro E, Ditto MC, Bruzzese V, Camellino D, Bianchi G, Serale F, Foti R, Amato G, DE Lucia F, Dal Bosco Y, Foti R, Reta M, Fiorenza A, Rovera G, Marchetta A, Focherini MC, Mascella F, Bernardi S, Sandri G, Giuggioli D, Salvarani C, DE Andres MI, Franchina V, Molica Colella F, Ferrero G, Ariani A. Lo Gullo A, et al. Among authors: vitetta r. Minerva Med. 2024 Aug;115(4):430-438. doi: 10.23736/S0026-4806.24.09409-6. Minerva Med. 2024. PMID: 39376099
Ixekizumab Retention Rate and Predictors of Treatment Persistence in Psoriatic Arthritis: Results of an Italian Multicenter Study.
Mazzanti C, Paroli M, Santoboni G, Addimanda O, Raffeiner B, Bezzi A, Visalli E, Celletti E, Farina A, Bernardi S, Larosa M, Andracco R, Del Medico P, Colella Molica AB, Giuggioli D, Lumetti F, Sandri G, Priora M, Serale F, Nucera V, Ometto F, Bravi E, Lo Gullo A, Scolieri P, Parisi S, Ravagnani V, Vitetta R, Marchetta A, Becciolini A, Angrisani C, De Simone M, Caccavalle R, Reta M, Magnani M, Mascella F, Foti R, Amato G, De Lucia F, Dal Bosco Y, Foti R, Di Penta M, Sabatini E, Del Biondo P, Girelli F, Camellino D, Bianchi G, Mansueto N, Smerilli G, Franchina V, Salvarani C, Ianniello A, Giampietro C, Di Donato E, Santilli D, Lucchini G, Arrigoni E, Platè I, Bruzzese V, Fusaro E, Ditto MC, Murgia D, Rovera G, Volpe A, Ferrero G, Adorni G, Molica FC, Ariani A. Mazzanti C, et al. Among authors: vitetta r. J Psoriasis Psoriatic Arthritis. 2025 May 13:24755303251342503. doi: 10.1177/24755303251342503. Online ahead of print. J Psoriasis Psoriatic Arthritis. 2025. PMID: 40376617 Free PMC article.
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group.
Cavagna L, Nuño L, Scirè CA, Govoni M, Longo FJ, Franceschini F, Neri R, Castañeda S, Sifuentes Giraldo WA, Caporali R, Iannone F, Fusaro E, Paolazzi G, Pellerito R, Schwarting A, Saketkoo LA, Ortego-Centeno N, Quartuccio L, Bartoloni E, Specker C, Pina Murcia T, La Corte R, Furini F, Foschi V, Bachiller Corral J, Airò P, Cavazzana I, Martínez-Barrio J, Hinojosa M, Giannini M, Barsotti S, Menke J, Triantafyllias K, Vitetta R, Russo A, Bogliolo L, Bajocchi G, Bravi E, Barausse G, Bortolotti R, Selmi C, Parisi S, Salaffi F, Montecucco C, González-Gay MA; AENEAS (American and European NEtwork of Antisynthetase Syndrome) Collaborative Group. Cavagna L, et al. Among authors: vitetta r. Clin Rev Allergy Immunol. 2017 Feb;52(1):71-80. doi: 10.1007/s12016-016-8528-9. Clin Rev Allergy Immunol. 2017. PMID: 26782036 Review.
Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort Study.
Paroli M, Becciolini A, Bravi E, Andracco R, Nucera V, Parisi S, Ometto F, Lumetti F, Farina A, Del Medico P, Colina M, Lo Gullo A, Ravagnani V, Scolieri P, Larosa M, Priora M, Visalli E, Addimanda O, Vitetta R, Volpe A, Bezzi A, Girelli F, Molica Colella AB, Caccavale R, Di Donato E, Adorni G, Santilli D, Lucchini G, Arrigoni E, Platè I, Mansueto N, Ianniello A, Fusaro E, Ditto MC, Bruzzese V, Camellino D, Bianchi G, Serale F, Foti R, Amato G, De Lucia F, Dal Bosco Y, Foti R, Reta M, Fiorenza A, Rovera G, Marchetta A, Focherini MC, Mascella F, Bernardi S, Sandri G, Giuggioli D, Salvarani C, Franchina V, Molica Colella F, Ferrero G, Ariani A. Paroli M, et al. Among authors: vitetta r. Medicina (Kaunas). 2023 Aug 17;59(8):1480. doi: 10.3390/medicina59081480. Medicina (Kaunas). 2023. PMID: 37629770 Free PMC article.
A consensus-based approach on the management of patients with both psoriasis and psoriatic arthritis in the dermatological and rheumatological settings in Italy: The ADOI PSO-Amore Project.
Cusano F, Sampogna F, Brunasso Vernetti AMG, Stisi S, Sandri G, Malara G, Naldi L, Pellegrino M, Tripepi GL, di Luzio Paparatti U, Agnusdei CP, Bonifati C, Celano A, Corazza V, D'Agostino F, De Pasquale R, Filippucci E, Foti R, Galdo G, Gai F, Ganzetti G, Graceffa D, Maccarone M, Mazzotta A, Melchionda G, Molinaro F, Paoletti F, Tonolo S, Vercellone A, Vitetta R, Massone C, Sebastiani GD. Cusano F, et al. Among authors: vitetta r. Dermatol Reports. 2022 Sep 26;14(3):9541. doi: 10.4081/dr.2022.9541. eCollection 2022 Sep 14. Dermatol Reports. 2022. PMID: 36199897 Free PMC article.
14 results